Sponsor:
M.D. Anderson Cancer Center
Code:
NCT07311746
Conditions
T-cell Prolymphocytic Leukemia
Refractory T-Cell Prolymphocytic Leukemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ruxolitinib
Cladribine
Venetoclax
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-17. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-07-15.